Zhi-feng Q. Xi

1630 Dongfang Road
Dongfang, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Journal: Cell discovery

Published: December 10, 2025

Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Journal: Cell discovery

Published: February 26, 2025

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation.

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation.

Journal: Clinical and molecular hepatology

Published: April 30, 2024

Development of a deep learning model for predicting recurrence of hepatocellular carcinoma after liver transplantation.

Development of a deep learning model for predicting recurrence of hepatocellular carcinoma after liver transplantation.

Journal: Frontiers in medicine

Published: January 19, 2024

Pediatric liver transplantation: progress in optimizing long-term outcomes and directions for future research.

Pediatric liver transplantation: progress in optimizing long-term outcomes and directions for future research.

Journal: Science bulletin

Published: December 22, 2022

Two-Dimensional Shear Wave Elastography Evaluation of Post-transplantation Complications in Pediatric Receipt: A Retrospective Cohort.

Two-Dimensional Shear Wave Elastography Evaluation of Post-transplantation Complications in Pediatric Receipt: A Retrospective Cohort.

Journal: Frontiers in pediatrics

Published: April 12, 2022

Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review.

Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review.

Journal: Frontiers in immunology

Published: January 14, 2021

Reply to: IL-26 and the prognosis of hepatocellular carcinoma after resection.

Reply to: IL-26 and the prognosis of hepatocellular carcinoma after resection.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: May 22, 2019

Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection.

Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: October 11, 2018

Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis.

Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis.

Journal: International journal of biological sciences

Published: March 14, 2018

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma.

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma.

Journal: BMC cancer

Published: September 27, 2017

Clinical analysis of liver transplantation in autoimmune liver diseases.

Clinical analysis of liver transplantation in autoimmune liver diseases.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: June 04, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026